At the weekend in Kampala, a piece of news landed that could reshape the future of one of the world’s most neglected diseases. The United States Patent and Trademark Office (USPTO) had accepted a ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...

Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced ...

Gene-editing citrus fruits to make them less bitter could not only encourage more people to eat them, it might also help save the industry from a devastating plague ...

Researchers found a "garbage man" enzyme that tags toxic clumps of proteins in the brain for removal, and saw a correlation ...

Gene editing sounds like progress until it becomes policy. This story follows a future where CRISPR and AI reshape humanity in the name of perfection. Diseases vanish, IQ rises, and society stabilizes ...

Kyle Muldoon joined the project in December 2024 while his son's life-threatening genetic condition was being treated at CHOP ...

Researchers identified AlCas12a, a compact, versatile enzyme that improves CRISPR gene editing and enables faster molecular ...

Spanish researchers discover AlCas12a, a groundbreaking enzyme for next-generation gene editing.The protein, discovered in wastewater, is smaller, ...

Phacilitate’s annual event dawns as cell and gene therapies reach a new tipping point: the science has hit new heights just ...

For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...